BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23117580)

  • 1. Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype.
    Simpson NE; Tryndyak VP; Pogribna M; Beland FA; Pogribny IP
    Epigenetics; 2012 Dec; 7(12):1413-20. PubMed ID: 23117580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
    Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
    Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents.
    Pogribny IP; Tryndyak VP; Pogribna M; Shpyleva S; Surratt G; Gamboa da Costa G; Beland FA
    Int J Oncol; 2013 May; 42(5):1822-32. PubMed ID: 23483119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
    Tryndyak VP; Kovalchuk O; Pogribny IP
    Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
    Kala R; Shah HN; Martin SL; Tollefsbol TO
    BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation.
    Li D; Bi FF; Cao JM; Cao C; Liu B; Yang Q
    Mol Cancer; 2014 Feb; 13():26. PubMed ID: 24502362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer.
    Salz T; Deng C; Pampo C; Siemann D; Qiu Y; Brown K; Huang S
    Mol Cancer Res; 2015 Mar; 13(3):461-9. PubMed ID: 25373480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters.
    Mungamuri SK; Wang S; Manfredi JJ; Gu W; Aaronson SA
    Oncogene; 2015 May; 34(19):2461-70. PubMed ID: 25023704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets.
    Chekhun VF; Lukyanova NY; Kovalchuk O; Tryndyak VP; Pogribny IP
    Mol Cancer Ther; 2007 Mar; 6(3):1089-98. PubMed ID: 17363502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
    Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
    Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of MDA-MB-231 cell proliferation by GSK-3β involves epigenetic modifications under high glucose conditions.
    Gupta C; Kaur J; Tikoo K
    Exp Cell Res; 2014 May; 324(1):75-83. PubMed ID: 24704462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Kar S; Patra SK
    Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
    Duvall-Noelle N; Karwandyar A; Richmond A; Raman D
    Oncogene; 2016 Mar; 35(9):1122-33. PubMed ID: 25982273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
    Milutinovic S; Brown SE; Zhuang Q; Szyf M
    J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
    Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
    Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.
    Dong C; Wu Y; Yao J; Wang Y; Yu Y; Rychahou PG; Evers BM; Zhou BP
    J Clin Invest; 2012 Apr; 122(4):1469-86. PubMed ID: 22406531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
    Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
    Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive.
    Guccione E; Bassi C; Casadio F; Martinato F; Cesaroni M; Schuchlautz H; Lüscher B; Amati B
    Nature; 2007 Oct; 449(7164):933-7. PubMed ID: 17898714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.